Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Major Depression and Heart Disease: Treatment Trials.

Shores1, Pascualy, Veith

  • 1Department of Veteran Affairs, University of Washington School of Medicine, Seattle, WA

Seminars in Clinical Neuropsychiatry
|March 20, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abdominal Aortic Aneurysms.

Current treatment options in cardiovascular medicine·2000
Same author

C2-symmetric planar chiral ferrocene diamides by (-)-sparteine-mediated directed ortho-lithiation. Synthesis and catalytic activity

Organic letters·2000
Same author

The First Crystal Structure of a Germanium(II) Amide with a Germanium - Lithium Bond and Its Behavior Towards Oxygen and Water.

Angewandte Chemie (International ed. in English)·2000
Same author

Reply

Journal of vascular surgery·1999
Same author

Introduction

Seminars in immunology·1999
Same author

Regarding "Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: Do the results justify an attempt before bypass grafting?"

Journal of vascular surgery·1999

Treating depression in cardiac patients is crucial for public health. New antidepressants and psychosocial interventions show promise in reducing cardiac risks and improving outcomes.

Area of Science:

  • Cardiology
  • Psychiatry
  • Public Health

Background:

  • Depression significantly increases cardiac morbidity, mortality, and healthcare costs.
  • Antidepressants like TCAs have cardiovascular effects, while newer SSRIs and bupropion show a better profile.
  • Psychosocial factors impact cardiac outcomes, and interventions may reduce risks.

Purpose of the Study:

  • To review current understanding of depression's impact on cardiac disease.
  • To evaluate the efficacy and cardiovascular safety of various antidepressant treatments.
  • To explore the role of psychosocial interventions in managing cardiac patients.

Main Methods:

  • Literature review of psychopharmacological and psychosocial treatment trials.
  • Analysis of studies on mental stress and cardiac ischemia.

Related Experiment Videos

  • Inclusion of ongoing large clinical trials for post-MI patients.

    • Main Results:

    • Tricyclic antidepressants (TCAs) have antiarrhythmic effects but higher cardiovascular risks.
    • Bupropion and selective serotonin reuptake inhibitors (SSRIs) appear safer but require larger studies.
    • Psychosocial interventions show potential benefits, though some trials have mixed results.

    Conclusions:

    • Effective treatment for depression in cardiac patients is vital for reducing mortality and morbidity.
    • Further large-scale trials are needed to confirm the safety and efficacy of new treatments.
    • Integrated pharmacological and psychosocial approaches may enhance patient quality of life.